Xilio Therapeutics Inc XLO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/10/24 EDT
1.19quote price arrow up+0.01 (+0.79%)
Volume
1,137
Close
1.18quote price arrow down-0.08 (-6.35%)
Volume
229,336
52 week range
0.49 - 3.25
Loading...
  • Open1.30
  • Day High1.30
  • Day Low1.11
  • Prev Close1.26
  • 52 Week High3.25
  • 52 Week High Date05/30/23
  • 52 Week Low0.49
  • 52 Week Low Date12/20/23

Key Stats

  • Market Cap43.556M
  • Shares Out36.91M
  • 10 Day Average Volume0.21M
  • Dividend-
  • Dividend Yield-
  • Beta-0.09
  • YTD % Change114.55

KEY STATS

  • Open1.30
  • Day High1.30
  • Day Low1.11
  • Prev Close1.26
  • 52 Week High3.25
  • 52 Week High Date05/30/23
  • 52 Week Low0.49
  • 52 Week Low Date12/20/23
  • Market Cap43.556M
  • Shares Out36.91M
  • 10 Day Average Volume0.21M
  • Dividend-
  • Dividend Yield-
  • Beta-0.09
  • YTD % Change114.55

RATIOS/PROFITABILITY

  • EPS (TTM)-2.78
  • P/E (TTM)-0.42
  • Fwd P/E (NTM)-0.81
  • EBITDA (TTM)-77.233M
  • ROE (TTM)-107.25%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)9.00%

EVENTS

  • Earnings Date08/11/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Xilio Therapeutics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Xilio Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The Company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index...
Paul Clancy
Independent Chairman of the Board
Rene Russo Pharm.D.
President, Chief Executive Officer, Director
Christopher Frankenfield
Chief Operating Officer
Address
828 Winter Street, Suite 300
Waltham, MA
02451
United States

Top Peers

SYMBOLLASTCHG%CHG
MTNB
Matinas BioPharma Holdings Inc
0.1756-0.0011-0.6225%
INAB
IN8BIO, Inc.
1.01UNCHUNCH
NXTC
NextCure Inc
1.65-0.07-4.07%
CKPT
Checkpoint Therapeutics Inc
1.50-0.06-3.85%
TIL
Instil Bio Inc
11.58+0.35+3.12%